Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Nutex Health (NUTX) Non-Current Deffered Revenue (2016)

Nutex Health (NUTX) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $497088.0 as the latest value for Q3 2016.

For Q3 2016, Non-Current Deffered Revenue changed N/A year-over-year to $497088.0; the TTM value through Sep 2016 reached $497088.0, changed N/A, while the annual FY2015 figure was $379052.0, N/A changed from the prior year.
Non-Current Deffered Revenue hit $497088.0 in Q3 2016 for Nutex Health, up from $453823.0 in the prior quarter.
Across five years, Non-Current Deffered Revenue topped out at $497088.0 in Q3 2016 and bottomed at $379052.0 in Q4 2015.